BlackRock Fund Advisors’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $90K | Buy |
38,641
+8,640
| +29% | +$20.1K | ﹤0.01% | 3636 |
|
|
2016
Q3 | $50K | Buy |
30,001
+3,159
| +12% | +$5.27K | ﹤0.01% | 3779 |
|
|
2016
Q2 | $28K | Sell |
26,842
-3,994,330
| -99% | -$4.17M | ﹤0.01% | 3876 |
|
|
2016
Q1 | $3.5M | Sell |
4,021,172
-86,313
| -2% | -$75.1K | ﹤0.01% | 2912 |
|
|
2015
Q4 | $4.97M | Buy |
4,107,485
+78,174
| +2% | +$94.6K | ﹤0.01% | 2837 |
|
|
2015
Q3 | $6.85M | Buy |
4,029,311
+68,979
| +2% | +$117K | ﹤0.01% | 2598 |
|
|
2015
Q2 | $8.24M | Buy |
3,960,332
+652,361
| +20% | +$1.36M | ﹤0.01% | 2619 |
|
|
2015
Q1 | $8.97M | Buy |
3,307,971
+64,194
| +2% | +$174K | ﹤0.01% | 2500 |
|
|
2014
Q4 | $8.34M | Buy |
3,243,777
+429,797
| +15% | +$1.1M | ﹤0.01% | 2566 |
|
|
2014
Q3 | $5.15M | Sell |
2,813,980
-85,306
| -3% | -$156K | ﹤0.01% | 2739 |
|
|
2014
Q2 | $7.74M | Sell |
2,899,286
-273,537
| -9% | -$730K | ﹤0.01% | 2576 |
|
|
2014
Q1 | $11.1M | Buy |
3,172,823
+94,523
| +3% | +$331K | ﹤0.01% | 2340 |
|
|
2013
Q4 | $13.8M | Sell |
3,078,300
-114,635
| -4% | -$513K | ﹤0.01% | 2195 |
|
|
2013
Q3 | $13M | Buy |
3,192,935
+382,914
| +14% | +$1.55M | ﹤0.01% | 2205 |
|
|
2013
Q2 | $11.7M | Buy |
+2,810,021
| New | +$11.7M | ﹤0.01% | 2172 |
|